Cipta Sarana Medika Tbk. vs Surya Fajar Capital Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Surya Fajar Capital Tbk. trades at Rp1,965 (market cap 2.69T, 43.9K 24h volume). The key difference: Surya Fajar Capital Tbk. is far larger — about 17× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (8.21M versus 43.9K). Which is the better fit depends on your goals.
| DKHH | SFAN | |
|---|---|---|
Market Cap | 158.12B | 2.69T |
Volume | 8.21M | 43.9K |
Lot | 82.15K | 439 |
Turnover | 515.2M | 86.38M |
Average Price | 62.72 | 1,967.59 |
Value | 515.2M | 86.38M |
Indicative Equilibrium Price | 63 | — |
Indicative Equilibrium Volume | 1.33K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Surya Fajar Capital Tbk (the Company) was established based on Notarial Deed No. 12 dated April 5, 2016 of Humberg Lie, S.H., S.E., M.Kn., a public notary in North Jakarta.
Read more on SFAN →